Article
Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
Bullish
78.2
−100 Bearish
0
+100 Bullish
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
CNBC Top Stories
Published
Apr 10, 2026 · 6:38 am
Article ID
y144q9z
Original URL
Open source
Sentiment Signal
Bullish
78.2
−100Neutral+100
More Like This